WHO Global Market Study on respiratory syncytial virus immunization products

MI4A produces antigen-specific market studies, analyzing global demand and supply dynamics for products targeting a specific antigen.

The Global Market Study on RSV Immunization Products aims to identify early potential obstacles to equitable access to RSV vaccines and monoclonal antibodies across all regions and income groups, based on current and forecasted future market dynamics.

This Working Document has been issued in November 2024, as an update to the September 2024 version following the SAGE recommendation.